Clinical Trial Update: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Sutetinib Maleate Capsule for locally advanced or metastatic non-small cell lung cancer; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sutetinib Maleate Capsule (sutetinib maleate)

Snippet

Sponsor: Teligene US | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING